Pollinex Quattro Grass
Allergenexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Oct 19, 2020 (NCT04687059)
Timeline
Indications
Mechanism of action
- Grass allergenImmunity, desensitized
Grass allergen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05540717 | Phase 3 | Oct 11, 2022 | Allergy Therapeutics |
| NCT04687059 | Phase 2/Phase 3 (Phase 3) | Oct 19, 2020 | Allergy Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allergy Therapeutics | For profit | 2 | 2 | 1 | 2020 |
1 organizations
Page 1 / 1